Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KCultivator Q&A: Bo Nelson percolates on positive energy in his Crossroads coffee shop
Editor’s note: KCultivators is a lighthearted profile series to highlight people who are meaningfully enriching Kansas City’s entrepreneurial ecosystem. The KCultivator Series is sponsored by WeWork Corrigan Station, a modern twist on Kansas City office space.Holding a red, Thou Mayest-branded mug, Bo Nelson credited the success of his 18th Street coffee shop to family talent,…
Scoops and fruit loops: Quirky collaboration melds Crumble candles, Betty Rae’s Ice Cream
Brandon Love hungered for a Kansas City brand as unconventional as his own high-growth aroma confectionery, Crumble Co. He found his match at Betty Rae’s. “I started trying to pick apart [potential partners] to see who would be the best fit,” said Love, Crumble Co.’s founder and “head fruit loop in charge.” “Our way’s really…
Bridge Space opens doors to creativity, collaboration in Lee’s Summit (Photos)
Set against the historic backdrop of the former Lee’s Summit post office, the past and present intentionally collide to create Bridge Space — a 13,000-square-foot coworking space that elevates entrepreneurs in the city’s bustling downtown business district, said Ben Rao. “I’m in the hospitality business. It’s about this experience that people have. We’re not just…
Fountain City FinTech first cohort named; could draw coastal, international companies to KC
A half-dozen companies from outside Kansas City earned spots among the first cohort of Fountain City FinTech, said Zach Pettet, hopeful the metro could attract the firms to stay or build long-term partnerships. “There’s a good chance that a number of firms will be putting down roots and creating jobs in Kansas City. We don’t…